Passage Bio, Inc.PASGNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank14
3Y CAGR-35.3%
5Y CAGR-22.4%
Year-over-Year Change
Research and development spending
3Y CAGR
-35.3%/yr
vs +75.0%/yr prior
5Y CAGR
-22.4%/yr
Recent deceleration
Acceleration
-110.4pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $23.28M | -42.1% |
| 2024 | $40.18M | -32.5% |
| 2023 | $59.56M | -30.8% |
| 2022 | $86.05M | -26.9% |
| 2021 | $117.67M | +42.1% |
| 2020 | $82.79M | +173.8% |
| 2019 | $30.24M | +229.9% |
| 2018 | $9.17M | - |